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Abstract
Obtaining high-resolution information from a complex system, while maintaining the global
perspective needed to understand system function, represents a key challenge in biology. Here we
address this challenge with a method (termed CLARITY) for the transformation of intact tissue
into a nanoporous hydrogel-hybridized form (crosslinked to a three-dimensional network of
hydrophilic polymers) that is fully assembled but optically transparent and macromolecule-
permeable. Using mouse brains, we show intact-tissue imaging of long-range projections, local
circuit wiring, cellular relationships, subcellular structures, protein complexes, nucleic acids and
neurotransmitters. CLARITY also enables intact-tissue in situ hybridization,
immunohistochemistry with multiple rounds of staining and de-staining in non-sectioned tissue,
and antibody labelling throughout the intact adult mouse brain. Finally, we show that CLARITY
enables fine structural analysis of clinical samples, including non-sectioned human tissue from a
neuropsychiatric-disease setting, establishing a path for the transmutation of human tissue into a
stable, intact and accessible form suitable for probing structural and molecular underpinnings of
physiological function and disease.
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The extraction of detailed structural and molecular information from intact biological
systems has long been a fundamental challenge across fields of investigation, and has
spurred considerable technological innovation1–8. The study of brain structure–function
relationships in particular may benefit from intact-system tools9–12, and in general, much
valuable information on intra-system relationships and joint statistics will be accessible from
full structural analysis of intact systems rather than piecemeal reconstruction across
preparations. Yet even tissue structure in itself provides only a certain level of insight
without detailed molecular phenotyping13,14, which is difficult to achieve within intact
tissue.
Current pioneering methods suitable for the mammalian brain either involve sectioning and
reconstruction, or are incompatible with molecular phenotyping, or both. Automated
sectioning methods have been successfully used to map structure4,5,15–18, in some cases
with molecular labelling. However, detailed reconstruction has typically been limited in
application to small volumes of tissue. On the other hand, intact-imaging methods that
extend the depth of light microscopy by reducing light scattering have emerged19–21, but
these preparations are incompatible with intact-tissue molecular phenotyping, and require
many weeks of preparation to achieve partial tissue clearing. Studying intact systems with
molecular resolution and global scope remains an unmet goal in biology.
We set ourselves the goal of rapidly transforming intact tissue into an optically transparent
and macromolecule-permeable construct while simultaneously preserving native molecular
information and structure. We took note of the fact that packed lipid bilayers are implicated
in rendering tissue poorly accessible—both to molecular probes and to photons—by creating
diffusion-barrier properties relevant to chemical penetration, as well as light-scattering
properties at the lipid–aqueous interface22,23. If lipid bilayers could be removed non-
destructively, light and macromolecules might penetrate deep into the tissue, allowing three-
dimensional imaging and immunohistological analysis without disassembly. But removing
lipid membranes that provide structural integrity and retain biomolecules would inevitably
damage tissue with profound loss of cellular and molecular information. Therefore the
provision of a physical framework would first be required to physically support the tissue
and secure biological information. We have developed and used such a technology, which
we term CLARITY, that addresses these challenges.
Hydrogel-electrophoretic tissue transmutation
We began by infusing hydrogel monomers (here, acrylamide and bisacrylamide),
formaldehyde and thermally triggered initiators into tissue at 4 °C (Fig. 1). In this step,
formaldehyde not only crosslinks the tissue, but also covalently links the hydrogel
monomers to biomolecules including proteins, nucleic acids and small molecules. Next,
polymerization of the biomolecule-conjugated monomers into a hydrogel mesh was
thermally initiated by incubating infused tissue at 37 °C for 3 h, at which point the tissue and
hydrogel became a hybrid construct. This hydrogel–tissue hybridization physically supports
tissue structure and chemically incorporates biomolecules into the hydrogel mesh.
Importantly, lipids and biomolecules lacking functional groups for conjugation remain
unbound and therefore can be removed from the hybrid. To extract lipids efficiently, we
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developed an ionic extraction technique rather than using hydrophobic organic
solubilization, for two main reasons. First, although organic solvents can extract lipids or
reduce refractive-index variations19,20,24, these solvents quench fluorescence, thereby
limiting imaging time. Light-sheet microscopy has been used to image benzyl alcohol/
benzyl benzoate (BABB)-treated samples while fluorescence persists19,20, but this approach
is less compatible with slower high-resolution imaging. Moreover, instability of native
fluorescence in BABB constrains imaging of fine neuronal projections or other modest
signals that can be easily quenched. Conversely, in the hydrogel–tissue hybrid all
fluorescent proteins tested, including green, yellow and red fluorescent proteins (GFP, YFP
and RFP, respectively), were robust to ionic detergent extraction (Fig. 2, Supplementary Fig.
1 and Supplementary Video 1). Second, whereas passive diffusion of detergent micelles
would take many months to completely extract lipids from the adult mouse brain, we
developed an active-transport organ-electrophoresis approach, which we term
electrophoretic tissue clearing (ETC), that capitalizes on the highly charged nature of ionic
micelles. This method expedites the extraction by orders of magnitude (Fig. 1 and
Supplementary Fig. 2). We anticipated that the hydrogel would secure biomolecules and fine
structural features such as membrane-localized proteins, synapses and spines in place,
whereas membranous lipids that cause light scattering and prevent penetration of
macromolecules would be actively removed, leaving behind an otherwise fully assembled
biological system suitable for labelling and imaging intact.
Whole adult mouse brain imaging
To test anticipated features of the technology, we processed with CLARITY (hereafter
‘clarified’) the brain of a 3-month-old line-H mouse, in which the cytosolic fluorescent
protein enhanced YFP (eYFP), under control of the Thy1 promoter sequence region, is
expressed in a subset of projection neurons25,26. Within 8 days, the intact adult brain was
transmuted into a lipid-extracted and structurally stable hydrogel–tissue hybrid. Scattering
still occurs owing to heterogeneously distributed protein and nucleic acid complexes in the
hybrid; however, after immersion in refractive-index-specified solutions matching the
CLARITY hybrid (for example, 85% glycerol or FocusClear, both with a refractive index of
~1.45), the intact brain (including heavily myelinated white matter, thalamus and brainstem)
becomes uniformly transparent (Fig. 2a–c and Supplementary Videos 2–5). ETC is crucial:
passive refractive-index matching of non-ETC-processed brain provided little clearing
(Supplementary Fig. 3), whereas full CLARITY processing enabled imaging of the entire
intact mouse brain at cellular resolution even using single-photon microscopy (Fig. 2d–f and
Supplementary Videos 2–5); this is important as many dyes and fluorescent proteins are
better suited to single-photon rather than two-photon illumination27,28).
Because imaging depth in clarified tissue appeared to be limited only by the working
distance of the objective (here 3.6 mm, although 8-mm working distance/0.9 numerical
aperture objectives are available), to image the 5–6-mm-thick adult mouse brain, we next
imaged the dorsal half of the brain followed by inversion and imaging of the ventral half
(Fig. 2d, e). Figure 2f shows a volume of unsectioned mouse brain with visualization
through the cortex, hippocampus and thalamus (Fig. 2g–l and Supplementary Video 2). We
observed that tissue expanded with ETC and returned to its original size after refractive-
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index matching; this transient change did not cause net tissue deformation, and remaining
secured in place were fine structural details such as membrane-localized proteins (Fig. 2m),
dendritic spines (Fig. 2n) and synaptic puncta (Fig. 3e–g). We found that clarified tissue
may be compatible with downstream electron microscopy, retaining key ultrastructural
features such as synapses and postsynaptic densities, although with current methods not all
relevant ultrastructures are apparent, probably owing to lack of membrane lipids
(Supplementary Fig. 4). CLARITY thus allows rapid high-resolution optical access to dense
intact tissue and, if needed, subsequent electron microscopy analysis. We next sought to
determine whether this design enabled intact-tissue molecular phenotyping.
Molecular phenotyping of intact-tissue volumes
Interrogating molecular features at subcellular resolution in an intact brain with known
global wiring properties may be of value; however, conventional labelling techniques
involve: (1) loss of native molecules after the permeabilization required for access to
intracellular targets29; (2) time-intensive thin sectioning and reconstruction5; or (3) damage
when multiple rounds of labelling are attempted due to harsh proberemoval processes5,30–32.
We anticipated that CLARITY could allow intact-tissue and multiple-round molecular
phenotyping by overcoming these three main difficulties. First, CLARITY may preserve
native antigens with unusual completeness owing to the hydrogel-hybridization process. To
quantify molecular preservation associated with tissue–hydrogel fusion, we compared
protein loss in clarified mouse brain to loss from conventional methods (Fig. 3a). Of total
protein, ~65% was solubilized (lost) when conventionally paraformaldehyde (PFA)-fixed
tissue blocks were cleared by 4% SDS for 1 week. Scale, a tissue-clearing method using 4M
urea, allowed ~41% protein loss over the same interval. Even PFA-fixed tissue treated only
with 0.1% Triton X-100 in PBS buffer, a mild detergent-based permeabilization solution
used in conventional histology, allowed ~24% loss of protein. However, when hydrogel-
hybridized tissue was cleared with the stringent 4% SDS solution of CLARITY, only ~8%
protein loss was seen, indicating that chemical tethering of biomolecules into hydrogel mesh
can enhance the preservation of molecular tissue components.
Second, we found that CLARITY, which increases tissue permeability by replacing lipid
bilayers with nanoporous hydrogel, enabled rapid diffusion of molecular probes deep into
intact tissue, and therefore allows access to preserved biomolecules without sectioning. In a
1-mm-thick clarified coronal block of mouse brain, uniformly antibody stained over 3 days
(Fig. 3b and Supplementary Video 6), quantitative co-localization analysis revealed that
eYFP fluorescence and anti-GFP staining overlapped throughout the block (Fig. 3c, d). We
next wanted to know whether whole-mount mouse brain immunolabelling was possible;
although the lipid-cleared brain is highly permeable, it was possible that antibodies would
not diffuse throughout the tissue on practical timescales. We conducted
immunohistochemistry for tyrosine hydroxylase in clarified intact mouse brain, and found
that 2 weeks of incubation each for primary and secondary antibody enabled 2.5 mm of
penetration from each surface, enough to stain ~5-mm-thick adult mouse brains
(Supplementary Fig. 5 and Supplementary Video 7). Tyrosine-hydroxylase-positive cell
bodies and projections were readily visualized throughout the brain, and only at the deepest
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point was moderate signal attenuation seen, indicating that antibody penetration was not
quite maximized and may be further enhanced by tuning conditions.
To investigate axonal projections of the tyrosine hydroxylase neurons further, we clarified,
tyrosine-hydroxylase-stained and imaged 1-mm-thick coronal blocks of mouse brain using a
high numerical aperture objective (0.95). As shown in Fig. 3j, k, Supplementary Figs 6–8
and Supplementary Video 8, projections of tyrosine-hydroxylase-positive fibres were readily
visualized in the neocortex, nucleus accumbens, caudate–putamen and amygdala.
Interestingly, certain cells in the infralimbic cortex and amygdala appeared much more
heavily invested by tyrosine hydroxylase fibres than neighbouring cells (Supplementary Figs
6f and 8 and Supplementary Video 8). Further supporting specificity of staining in clarified
tissue (Fig. 3j, k and Supplementary Fig. 7), visualized tyrosine hydroxylase projections
spared anterior commissure while heavily investing the surrounding nucleus accumbens and
caudate–putamen as expected.
We next considered that CLARITY could potentially enable analysis of subcellular
molecular architecture in large volumes with resolution at the diffraction limit of light
microscopy33, in an approach complementary to thin mechanical sectioning and three-
dimensional reconstruction5,34,35. Resolving submicron-scale structures deep in tissue poses
a challenge as the high numerical aperture objectives used for high-resolution imaging are
susceptible to optical aberration caused by refractive-index variations in tissue, which blurs
images and impairs differentiation of adjacent fluorescent signals, such as pre- and
postsynaptic puncta. But when a clarified 500-µm-thick block of Thy1–eYFP mouse brain
was immunolabelled for synapsin I (presynaptic) and PSD-95 (postsynaptic) and imaged
with a ×63 glycerol-immersion objective (numerical aperture, 1.3; working distance, 280
µm), throughout the tissue volume we could unequivocally identify individual paired pre-
and postsynaptic puncta, molecularly defining identity and position of putative excitatory
synapses (Fig. 3e–g). The full-width at half-maximum of the point-spread function was
uniform throughout the block, indicating that loss of resolution is negligible even near the
diffraction limit of conventional light microscopy (Fig. 3f, g and Supplementary Figs 9 and
10) and demonstrating another feature of the technique: removal of lipid membranes ensures
that tissue refractive index remains nearly constant throughout large volumes, allowing
high-resolution imaging. We also found that the CLARITY hydrogel-conjugation process
preserves small molecules such as the neurotransmitter GABA (γ-aminobutyric acid, Fig.
3h) and (for in situ hybridization) messenger RNAs (Fig. 3i), paving the way for multimodal
combinatorial labelling within unsectioned tissue.
Finally, CLARITY was found to enable multi-round molecular phenotyping; the stable
framework allowed effective removal of antibodies without fine structural damage or
degraded antigenicity. Traditional elution requires incubation in acidic buffer with
potassium permanganate (KMnO4) oxidation or heat, harsh treatments that cause antigen
loss and fluorescence quenching5,30–32. But in the hydrogel context of increased structural/
chemical stability, the ionic detergent (4% SDS/neutral-pH buffer) used initially to create
clarified tissue can be re-used to denature antibodies and disrupt binding, and the
permeability of clarified tissue can facilitate rapid antibody exchange. We performed three
consecutive rounds of staining in 1-mm-thick coronal blocks from a Thy1–eYFP H-line
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mouse brain (Fig. 4 and Supplementary Videos 10–14), observing effective antibody
removal and preserved eYFP-positive neuronal morphology as well as re-staining capability.
Although further quantification would be required to fully map the extent to which
CLARITY secures molecular information, this result shows that elution in clarified tissue
largely preserves integrity of tissue structure, cellular architecture, fluorescence signals (Fig.
4d–f) and 4′,6-diamidino-2-phenylindole (DAPI) DNA staining (Fig. 4g). Moreover,
repeated tyrosine hydroxylase staining in the first and third rounds maintained signal pattern
and intensity, confirming that antigenicity is retained throughout multiple rounds of staining
and elution.
Human tissue imaging and molecular phenotyping
CLARITY is, in principle, applicable to any tissue: adult zebrafish imaging and phenotyping
are demonstrated36 in Supplementary Fig. 12, and we also tested post-mortem human brains.
With important and rare tissue from clinical brain banks residing in formalin, one concern is
that these maximally crosslinked samples could be poorly suited to CLARITY, and certainly
the mapping of connectivity in the human brain (ref. 37 and http://
www.neuroscienceblueprint.nih.gov/connectome/) at cellular resolution has been hampered
by lack of methods for labelling individual neurites over distances, as the injection of dyes
into living brain or in vivo genetic labelling are feasible only in animals38,39. If extensively
fixed human tissues were suitable for CLARITY, new avenues would be opened for the
study of clinical samples.
We found that CLARITY was suitable for such long-banked human brain, allowing
immunohistological visualization and identification of neurons and projections over large
volumes (Fig. 5a–g and Supplementary Videos 15–17). In 0.5-mm-thick blocks of frontal
lobe from an autistic patient, stored in formalin for >6 years, we were able to stain for axons
with neurofilament protein and myelin basic protein, and trace individual fibres (Fig. 5e and
Supplementary Video 15). In addition, by staining for parvalbumin it was possible to
visualize the distribution of parvalbumin-positive neurons in the neocortex over large
volumes (6.7 × 4.7 × 0.5 mm), and trace individual parvalbumin-labelled processes (Fig.
5g–n and Supplementary Videos 16 and 17).
Unlike mechanical sectioning methods that may involve deformation of tissue and
uncertainty in registration across sections, CLARITY preserves continuity of structure,
which not only allows tracing of neurites over distances, but also provides a class of distinct
information about three-dimensional and topological morphology of traced neurons. As one
example, we found that many parvalbum-inpositive interneurons in this human sample,
particularly in deep layers, showed isoneuronal and heteroneuronal dendritic bridges (Fig.
5g–m, Supplementary Fig. 13, Supplementary Video 17 and Supplementary Table 2). These
ladder-like connections, not typical of age- and sexmatched normal brain (Supplementary
Fig. 14), instead resemble abnormalities observed with mutations in the Down syndrome
cell-adhesion molecule (Dscam) protein40 or protocadherins41; mutations in the latter family
are associated with autism-spectrum disorder42. Although extensive work would be required
to define the incidence and implications of abnormal parvalbumin neurons, the observation
illustrates the structural and molecular capability that clarified tissue provides by virtue of
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volumetric continuity, which may help to shed light on structural underpinnings of
neuropsychiatric disease.
Discussion
With this hydrogel–tissue fusion and electrophoretic-clearing technology, intact tissue can
be rapidly transformed into an optically and chemically accessible form while retaining
structural and molecular information, thereby enabling the imaging of entire adult vertebrate
brains as well as multiple-round molecular phenotyping without thin sectioning. Currently,
the non-corrected water-immersion objectives used, rather than clarified tissue properties,
represent the main limiting factor for maximizing imaging depth and resolution; specialized
adaptive optics or CLARITY-optimized long-working-distance objectives will further
enhance the acquisition of integrated structural and molecular information from intact
systems.
Turning immense data sets into useful insights remains a key challenge. Computational
approaches to image segmentation, three-dimensional registration and automated tracing
require further development. Moreover, for the subset of applications relevant to circuit
connectivity, CLARITY does not in itself supplant electron microscopy. However, the
potential electron microscopy compatibility of CLARITY (Supplementary Fig. 4) may offer
a two-step approach in probing connectivity with synaptic resolution; CLARITY with light
microscopy may first be used to visualize and trace fluorescently labelled neurons and
projections in the whole brain, followed by electron microscopy analysis of small volumes
to define the patterns and rules (for example, postsynaptic cell target type) followed by axon
terminals and synaptic contacts. Notably, owing to the absence of lipids, osmium tetroxide/
uranyl acetate staining alone with electron microscopy does not provide enough contrast to
identify all ultrastructural boundaries, and additional methodological tissue-preparation
work is indicated.
Although much remains to be refined, newly enabled access to intact-system properties may
dovetail with existing optogenetic-control or activity-imaging methods. For example, cells
studied in local and global structural detail with CLARITY could be the same cells
previously visualized for activity, or controlled to modulate performance, during
behavioural assays in the same organism with proper registration. Moreover, efficient
molecular phenotyping applied to immediate early gene products may help to map
populations with altered activity downstream of directly modulated populations, across the
same intact brain and in the context of global wiring maps. Together with its capability for
intersectional definition through multiple rounds of labelling, and broad application domain
(including mouse, zebrafish and human), these data suggest that CLARITY provides access
to structural and molecular information that may help to support integrative understanding
of large-scale intact biological systems.
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METHODS
CLARITY
CLARITY refers to transformation of intact biological tissue into a hybrid form in which
specific components are replaced with exogenous elements that provide new accessibility or
functionality. Initially, the term was an acronym to describe the Clear Lipid-exchanged
Acrylamide-hybridized Rigid Imaging/Immunostaining/In situ hybridization-compatible
Tissue-hYdrogel. However, CLARITY is more inclusively defined because infused
elements need not be exclusively hydrogel monomers or acrylamide-based, and the
properties of infused elements may be adjusted for varying degrees of clarity, rigidity,
macromolecule-permeability or other functionality.
Immunostaining of CLARITY-processed mouse brain tissue
For GFP staining shown in Fig. 3b–d, the clarified 1-mm-thick block of Thy1–eYFP line-H
mouse (2 months old) brain was incubated at 37 °C for 2 days in 0.1% Triton X-100 (wt/
vol), anti-GFP antibody conjugated with Alexa Fluor 594 (Invitrogen, 1:50 dilution), 1M
sodium borate buffer solution, pH 8.5, followed by wash at 37 °C for 1 day with 0.1% (wt/
vol) Triton X-100 and 1 M sodium borate buffer, pH 8.5. For tyrosine hydroxylase staining
of whole mouse brain in Supplementary Fig. 4, the clarified C57BL/6 mouse (4 weeks old)
brain was incubated at 37 °C for 2 weeks in 0.1% (wt/vol) Triton X-100, primary antibody
(dilution, 1:50), 0.5M sodium borate buffer solution, pH 8.5, followed by wash at 37 °C for
1 week with 0.1% (wt/vol) Triton X-100 and 0.5M sodium borate buffer, pH 8.5. The tissue
was then incubated at 37 °C for 2 weeks in 0.1% (wt/vol) Triton X-100, secondary antibody
(dilution, 1:50) and 0.5M sodium borate buffer solution, pH 8.5, followed by wash at 37 °C
for 1 week with 0.1% (wt/vol) Triton X-100 and 0.5M sodium borate buffer, pH 8.5. For
other staining, the clarified 1-mm-thick block of Thy1–eYFP H-line mouse (2 months old)
brain was incubated at 37 °C for 2 days in 0.1% (wt/vol) Triton X-100, primary antibody
(dilution, 1:50–1:100) and 1M sodium borate buffer solution, pH 8.5, followed by wash at
37 °C for 1 day with 0.1% (wt/vol) Triton X-100 and 1 M sodium borate buffer, pH 8.5. The
tissue was then incubated at 37 °C for 1 day in 0.1% (wt/vol) Triton X-100, secondary
antibody (dilution, 1:50 – 1:100) and 1M sodium borate buffer solution, pH 8.5, followed by
wash at 37 °C for 1 day with 0.1% (wt/vol) Triton X-100 and 1M sodium borate buffer, pH
8.5.
Immunostaining of CLARITY-processed post-mortem human brain tissue
Clarified 500-µm-thick blocks were incubated at 37 °C for 1 day in 0.1% (wt/vol) Triton
X-100, primary antibody (dilution, 1:50–1:100) and 1M sodium borate buffer solution, pH
8.5, followed by wash at 37 °C for 12 h with 0.1% (wt/vol) Triton X-100 and 1M sodium
borate buffer, pH 8.5. The tissue was then incubated at 37 °C for 1 day in 0.1% (wt/vol)
Triton X-100, secondary antibody (dilution, 1:50–1:100) and 1M sodium borate buffer
solution, pH 8.5, followed by wash at 37 °C for 12 h with 0.1% (wt/vol) Triton X-100 and 1
M sodium borate buffer, pH 8.5.
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Imaging of CLARITY-processed mouse brain tissue
For imaging the intact Thy1–eYFP H-line mouse brain (Fig. 2e), the clarified brain (3
months old) was incubated in FocusClear, a water-based immersion medium, for 2 days.
The brain was then enclosed between two coverglass-bottom Petri dishes. The dorsal half of
the brain was first imaged (stack size, 3.1 mm; step size, 20 µm) using a Leica SP5 system
equipped with the ×10 water-immersion objective (Leica HCX AOP L; numerical aperture,
0.30; working distance, 3.6) and 514-nm excitation. The mounted brain was then inverted
and the ventral half was imaged in the same way. To obtain the 3.4-mm-thick volume image
visualizing from the cortex to the thalamus (Fig. 2f–l), the intact line-H mouse brain was
mounted as described and imaged using the ×10 objective and 514-nm excitation (stack size,
3.4 mm; step size, 2 µm). The immunostained 1-mm-thick coronal blocks were incubated in
FocusClear for 1 day and enclosed between the coverglass-bottom Petri dish and slide glass.
The mounted samples were imaged using the ×10 objective and single-photon excitation
(514 nm, 591 nm and 654 nm).
Imaging of CLARITY-processed post-mortem human brain tissue
Clarified and immunostained tissues were incubated in FocusClear for 1 day and mounted as
described above. The tissues were then imaged using the Leica SP5 system equipped with
the ×25 water-immersion objective (Leica HCX IRAPOL; numerical aperture, 0.95;
working distance, 2.4 mm; stack size, 500 µm; step size, 0.5 µm).
Protein-loss measurement
Six PFA-fixed adult mouse (4 weeks old) brains (for 4% SDS, Scale and Triton X-100
treatments) and two (4 weeks old) PFA-fixed, hydrogel-embedded brains (for CLARITY)
were cut into 1-mm-thick coronal blocks. One half of each PFA-fixed brain was weighed
and placed in 2.5 ml of 4% SDS, ScaleU2 (a mixture of 4M urea and 30% glycerol) or 0.1%
Triton X-100 solution. One half of each PFA-fixed, hydrogel-embedded brain was placed in
2.5 ml of 4% SDS solution. The tissues were allowed to clear for 1 week at 37 °C in the
respective solutions and quantity of protein lost from tissue by diffusing into solution was
measured using the BCA (bicinchoninic acid) protein assay; total protein inmouse brain was
estimated at 10%(wt) on the basis of previous work45,46.
Experimental subjects
Animal husbandry and all aspects of animal care and euthanization as described were in
accordance with guidelines from the National Institutes of Health and have been approved
by members of the Stanford Institutional Animal Care and Use Committee. Use of post-
mortem human tissue was in accordance with guidelines from the National Institutes of
Health and approved by the Stanford Institutional Review Board.
Neurite tracing
Manual tracing of individual neurons was performed using Imaris software (Bitplane).
Neurons with cell bodies located in the middle 150 µm of the z-stack were randomly
sampled and chosen for tracing. The cell body was reconstructed semi-automatically
through a user-defined threshold that included as much of the cell body as possible but less
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than 5 µm of any dendrite. All neurites originating from the cell body were traced manually
in short segments in the ‘Surpass’ mode, and each segment was automatically centred (with
the opportunity for user corrections) before being connected. The number of
interconnections between filaments of the same cell, and the number of interconnections
between a filament from the traced cell and that of any other cell, was counted manually.
Separately, for Fig. 5h–n neurons with interesting structures were chosen non-randomly and
traced using the same method described above.
Basic CLARITY protocol
Hydrogel solution preparation: (1) Combine and mix 40 ml of acrylamide (40%), 10 ml of
bis-acrylamide (2%), 1g of VA-044 initiator (10% wt), 40 ml of ×10 PBS, 100 ml of 16%
PFA and 210 ml of dH2O with special attention to temperature and safety precautions. Keep
all components on ice at all times to prevent polymerization. Caution: PFA is an irritant,
sensitizer, carcinogen and toxin. Acrylamide is a potent neurotoxin, a respiratory and skin
sensitizer, carcinogen, irritant, mutagen, teratogen and reproductive hazard. Many of the
chemical constituents of hydrogels that could be used for CLARITY would fall into one or
more of these categories. Therefore, to avoid skin contact or inhalation of monomers and/or
crosslinkers (for example, acrylamide or PFA), solution preparation and all subsequent
handling of hydrogel solution and polymer must be conducted in a fume hood with personal
protective equipment including face shield, laboratory coat, gloves and closed-toe shoes.
Saponin is a widely used mild non-ionic surfactant often used to permeabilize cellular
membranes in conventional immunohistochemistry. In CLARITY, saponin can be used in
the hydrogel monomer infusion process to facilitate diffusion of the hydrogel monomer and
initiator into the tissue, particularly for samples in which cardiac perfusion is not feasible,
such as post-mortem human tissues and zebrafish brains. Saponin shortens incubation time
required in the hydrogel monomer infusion process. However, bubbles may form that could
be linked to saponin use, so routine saponin is not suggested. (2) Distribute 40-ml aliquots
into 50-ml conical tubes on ice. Each tissue sample will require the use of one 40-ml tube:
20 ml for perfusion and the remaining 20 ml for sample embedding. (3) Seal tubes tightly
and keep in secondary containment (on ice) before removing them from the hood. Transfer
aliquots from ice to −20 °C. Store these solutions at −20 °C until they are ready to be used.
They can be stored at −20 °C indefinitely if all components were kept sufficiently cold
during the preparation process.
Solution preparation: (1) Combine and mix 123.66 g boric acid, 400 g sodium dodecyl
sulphate, and 9 l dH2O. To avoid skin contact or inhalation, prepare solution in a fume hood
in proper PPE. Paying special attention to safety, combine water, boric acid and SDS while
stirring. Add dH2O to 10 l and add NaOH until the pH has reached 8.5. This solution can be
made, stored and used at room temperature (20 °C). Caution: SDS is a toxin and irritant to
the skin and respiratory system.
Transcardial perfusion with hydrogel solution: (1) Before perfusing, thaw the frozen
hydrogel monomer solution in the refrigerator or on ice. (2) When the solution is completely
thawed and transparent (but still ice cold), gently invert to mix. Make sure that there is no
precipitate and avoid introducing any bubbles into the solution. (3) Prepare perfusion
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materials within a fume hood. (4) Deeply anaesthetize adult mouse with Beuthanasia-D. (5)
Perfuse the animal transcardially, first with 20 ml of ice-cold 1× PBS and then 20 ml of the
ice-cold hydrogel solution. Maintain a slow rate of perfusion (about 2 min for the 20 ml of
each solution). (6) Immediately place the tissue (for example, brain) in 20 ml cold hydrogel
solution in a 50-ml conical tube. Keep the sample in solution on ice until it can be moved to
a 4 °C refrigerator. (7) Cover sample in aluminium foil if it contains fluorophores and
incubate at 4 °C for 2–3 days to allow for further diffusion of the hydrogel solution into the
tissue.
Hydrogel tissue embedding: (1) De-gas the 50-ml conical tube containing the sample in the
desiccation chamber (in a fume hood) to replace all of the gas in the tube with nitrogen (as
oxygen impedes hydrogel formation), as follows: place the 50-ml conical tube on a rack in
the desiccation chamber; twist the 50-ml conical tube open sufficiently to allow gas
exchange; turn on the nitrogen tank and adjust the control valve such that the inlet to the
desiccation chamber fills with nitrogen gas; switch the desiccation chamber valve from
nitrogen gas flow to the vacuum. Turn on the vacuum pump; verify that the chamber is
under full vacuum by testing the chamber lid. Keep vacuum on for 10 min; switch the
vacuum off and slowly turn the valve to fill the chamber with nitrogen gas; carefully open
the chamber just enough to reach the tubes while purging with nitrogen gas, taking great
care to minimize exposure to air, and quickly and tightly close the sample tube. (2)
Submerge the tube in 37 °C water bath in a 37 °C room or incubator on the rotator. Incubate
for 3 h or until solution has polymerized. (3) In a fume hood, extract the embedded sample
from the gel (carefully take the sample out and remove extra gel pieces with gloved fingers).
Hydrogel waste disposal should be conducted in accordance with all institutional, state and
country regulations for hydrogel monomers and crosslinkers (for example, acrylamide and
PFA). (4) Wash the sample with 50 ml clearing solution for 24 h at room temperature to
dialyse out extra PFA, initiator and monomer. Wash the sample twice more with 50 ml for
24 h, each at 37 °C to further reduce residual PFA, initiator and monomer. Take care to
dispose of this waste solution carefully as a biohazard.
ETC: (1) Construct the ETC chamber as described (http://CLARITYresourcecenter.org):
place the sample in the chamber, and circulate the clearing solution through the chamber
using the temperature-controlled water circulator, with 10–60V applied across the tissue (for
example, brain) at 37–50 °C for several days to clear the sample. The clearing process is
faster at higher voltage and temperature, but requires more power, limiting the number of
clearing set-ups simultaneously operable by one power supply (typical power output
maximum, 300 W). For example, four set-ups can be run simultaneously at 37 °C and 30 V,
whereas only two set-ups can be run at 50 °C and 60 V, so circulator temperature and
voltage should be chosen to meet practical considerations. In addition, too-high voltage
operation could cause bubble formation in the tissue and deposit of black particles on the
surface of tissue. Therefore, low voltage (10–40 V) is recommended. Note that lipids and
biomolecules lacking functional groups required for conjugation, such as native
phosphatidylinositol 4,5-bisphosphate or exogenous dextrans used for labelling, may be lost
during this process. (2) After several days, wash the sample twice with of PBST (0.1%
Triton X-100 in 1× PBS) twice for 24 h each.
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Preparing the sample for imaging: (1) Incubate the sample in FocusClear or 80% glycerol
solution for 2 days before imaging; these have refractive indices matching that of clarified
tissue. Ensure there is sufficient solution surrounding the sample, and that evaporative losses
do not occur. Protect the sample from light. (2) Take a clean glass slide and gently place it
on a dust-free surface. (3) Take a small piece of BluTack putty and prepare constant-
diameter worm shapes using gloved hands. Make the thickness uniform and about 1.5× the
thickness of the sample (for example, if the sample is 1 mm, make the putty tube diameter
1.5 mm). (4) Place two tubes of putty horizontally across the vertical slide, leaving space in
between for the tissue sample. Cut excess putty that protrudes off the slide. (5) Using a
spatula, carefully take the sample and place it between the putty tubes in the middle of the
slide. Pipette ~20 µl of FocusClear medium on top of the sample. (6) Carefully place a
Willco dish (with the lipped side facing up) on top of the putty tubes. Press down on the
glass part of the dish (keeping fingers over the putty to avoid glass shattering) carefully and
slowly until contact is made with the sample and FocusClear medium. Ensure that there are
no bubbles between the sample, medium, slide and dish. (7) Using a P200 pipette, carefully
introduce more FocusClear to either side of the sealed chamber (from the liquid that
surrounded the sample for incubation as it has been optically matched). Take great care not
to introduce any bubbles. (8) Now that the whole chamber is filled with FocusClear, use
PDMS sealant (Kwik-Sil) across both vertical openings between the putty, dish and slide to
fully seal the chamber and prevent evaporation. (9) Place aluminium foil on top of the
chamber and place it on a level surface (shielded from light to minimize photodamage).
Leave the sample for 10–15 min to allow the PDMS sealant to polymerize fully. (10)
Preparation is now ready for imaging.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. CLARITY
Tissue is crosslinked with formaldehyde (red) in the presence of hydrogel monomers (blue),
covalently linking tissue elements to monomers that are then polymerized into a hydrogel
mesh (followed by a day-4 wash step; Methods). Electric fields applied across the sample in
ionic detergent actively transport micelles into, and lipids out of, the tissue, leaving fine-
structure and crosslinked biomolecules in place. The ETC chamber is depicted in the boxed
region (Supplementary Fig. 2).
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Figure 2. Intact adult mouse brain imaging
Imaging was performed in adult mouse brains (3 months old). a, Cajal quote before
CLARITY. b, Cajal quote after CLARITY: Thy1–eYFP line-H mouse brain after hydrogel–
tissue hybridization, ETC and refractive-index matching (Methods). c, Fluorescence image
of brain depicted in b. d, Dorsal aspect is imaged (single-photon (1p) microscopy), then
brain is inverted and ventral aspect imaged. e, Three-dimensional rendering of clarified
brain imaged (×10 water-immersion objective; numerical aperture, 0.3; working distance,
3.6 mm). Left, dorsal half (stack size, 3,100 µm; step size, 20 µm). Right, ventral half (stack
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size, 3,400 µm; step size, 20 µm). Scale bar, 1 mm (Supplementary Videos 3–5). f, Non-
sectioned mouse brain tissue showing cortex, hippocampus and thalamus (×10 objective;
stack size, 3,400 µm; step size, 2 µm). Scale bar, 400 µm (Supplementary Video 2). g–l,
Optical sections from f showing negligible resolution loss even at ~3,400-µm deep: z=446
µm (g, h), z=1,683 µm (i, j) and z=3,384 µm (k, l). h, j and l, boxed regions in g, i and k,
respectively. Scale bars, 100 µm.m, Cross-section of axons in clarified Thy1–
channelrhodopsin2 (ChR2)–eYFP striatum: membrane-localized ChR2–eYFP (1-mm-thick
coronal block; ×63 glycerol-immersion objective; numerical aperture, 1.3; working distance,
280 µm). Scale bar, 5 µm. n, Dendrites and spines of neurons in clarified Thy1–eYFP line-H
cortex (1-mm-thick coronal block; ×63 glycerol objective). Scale bar, 5 µm.
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Figure 3. Molecular phenotyping in intact tissue
a, Protein loss in clarified mouse brain compared to conventional methods (see
Supplementary Information for more details); error bars denote s.e.m.; n=4 for each
condition. b, Rendering of a 1-mm-thick non-sectioned coronal block of Thy1–eYFP mouse
brain immunostained for GFP. The tissue was ETC-cleared (1 day), immunostained (3 days)
and imaged (×10 water-immersion objective; single-photon excitation). Left, eYFP (green);
middle, anti-GFP (red); right, overlay. Scale bar, 500 µm (Supplementary Video 6). c,
Three-dimensional rendering of the boxed region in the cortex in b shows eYFP
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fluorescence (left) and anti-GFP staining (right). d, Left, co-localization: Manders overlap
coefficient plotted versus depth43. Right, optical sections at different depths in three-
dimensional rendering. Scale bar, 100 µm. e, f, 500-µm-thick block of line-H mouse brain (2
months old) clarified for 1 day and immunostained for synapsin I (red) and PSD-95 (blue)
for 3 days (Methods) (×63 glycerol objective; single-photon excitation). e, Left, optical
sections (z=20 µm, z=200 µm). Right, enlarged images of boxed regions on left. Individual
synaptic puncta resolved throughout depth. White depicts eYFP staining. f, Average
immunofluorescence cross-section of PSD-95 puncta at z=20 µm (top) and z=200 µm
(bottom). g, Full width at half maximum (FWHM) of average immunofluorescence cross-
section of PSD-95 puncta versus depth. Insets, average puncta at z=20 µm and z=200 µm. h,
Hippocampal staining. Left, GABA; middle, parvalbumin (PV); right, overlay. 500-µm-
thick block of wild-type mouse brain (3 months) clarified (1 day) and immunostained (3
days) (×25 water-immersion objective; numerical aperture, 0.95; working distance, 2.5 mm;
single-photon excitation). Scale bar, 20 µm. i, in situ hybridization. Clarified 500-µm mouse
brain block showing dopamine receptor D2 (Drd2) mRNA in the striatum. LV, lateral
ventricle. Blue, DAPI. 50-base-pair RNA probes for Drd2 visualized with FastRed (×25
water-immersion objective; single-photon excitation (555 nm) for FastRed, two-photon
excitation (720 nm) for DAPI). Scale bars: left, 100 µm; right, 20 µm. j, k, Axonal fibres of
tyrosine hydroxylase (TH)-positive neurons in the nucleus accumbens (NAc) and caudate–
putamen (CPu). j, Three-dimensional rendering of 1-mm-thick clarified mouse brain block
stained for tyrosine hydroxylase (red) and DAPI (green). aca, anterior commissure. Scale
bar, 500 µm. k, Maximum projection, NAc/aca volume in j. Scale bar, 50 µm.
Chung et al. Page 19
Nature. Author manuscript; available in PMC 2014 July 10.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Multi-round molecular phenotyping of intact tissue
a, First round. Rendering of 1-mm-thick Thy1–eYFP block immunostained for tyrosine
hydroxylase in non-sectioned form. ETC-cleared (1 day) and immunostained (6 days). Scale
bar, 500 µm (Supplementary Video 10). b, Antibodies eluted from block in a (4% SDS, 60
°C for 0.5 days). Tyrosine hydroxylase signal was removed and eYFP fluorescence retained
(Supplementary Video 11). c, Second round. Three-dimensional rendering of same block
now immunostained for parvalbumin (red), glial fribrillary acidic protein (GFAP) (blue) and
DAPI (white) (Supplementary Video 12). d–f, Maximum projections of 100 µm volume of
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yellow-boxed regions in a, b and c, respectively. eYFP-positive neurons preserved. cp,
cerebral peduncle; SNR, substantia nigra. Scale bar, 100 µm. g, Optical section of white/
dotted-box region in c showing DAPI. CA, cornu ammonis; DG, dentate gyrus. Scale bar,
100 µm. h, i, Tyrosine hydroxylase channel of white box regions in a (h) and j (i). Tyrosine
hydroxylase antigenicity preserved through multiple elutions. Scale bar, 100 µm. j, Third
round. Block in a–c immunostained for tyrosine hydroxylase (red) and choline
acetyltransferase (ChAT) (blue) (Supplementary Video 13). k, Three-dimensional view of
hippocampus in c showing eYFP-expressing neurons (green), parvalbumin-positive neurons
(red) and GFAP (blue). Alv, alveus. Scale bar, 200 µm (Supplementary Video 14).
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Figure 5. Human brain structural/molecular phenotyping
Human BA10 500-µm-thick intact blocks clarified (1 day) and immunostained (3 days) (×25
water-immersion objective). a, Optical section: myelin basic protein (MBP) and
parvalbumin staining. White arrowheads indicate membrane-localized myelin basic protein
around parvalbumin-positive projections. Scale bar, 10 µm. b, Tyrosine hydroxylase and
parvalbumin staining (maximum projection; 120 µm volume; step size, 0.5 µm). Scale bar,
50 µm. c, Optical section: neurofilament (NP) and GFAP. Scale bar, 20 µm. d, Somatostatin
and parvalbumin staining (maximum projection; 63 µm volume; step size, 0.5 µm). Scale
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bar, 20 µm. e, Rendering of neurofilament-positive axonal fibres. Red, traced axon across
volume. Scale bar, 500 µm. Inset: boxed region. Scale bar, 20 µm (Supplementary Video
15). f, Visualization of parvalbumin-positive neurons in the neocortex of autism case; layers
identified as described in ref. 44. Scale bar, 500 µm (Supplementary Video 16). g, Yellow-
boxed region in f showing parvalbumin-positive cell bodies and fibres in layers 4, 5 and 6.
Three representative parvalbumin-positive interneurons in layer 6 with ladder-shaped
hetero- or iso-neuronal connections were traced (green, purple, blue). Scale bar, 100 µm
(Supplementary Video 17). h, Three-dimensional rendering of abnormal neurons in g;
yellow arrowheads (1, 2) indicate ladder-shaped structures shown below in i and k. Scale
bar, 80 µm. i, Zoomed-in maximum projection of 8 µm volume showing morphology of
ladder-shaped structure formed by neurites from a single neuron. Scale bar, 10 µm. j,
Tracing of structure in i. k, Maximum projection of 18 µmvolume showing ladder-shaped
structure formed by neurites from two different neurons. Scale bar, 10 µm. l, Tracing of
structure in k. m, Iso- and hetero-neuronal dendritic bridges per neuron. Neurons selected
randomly and traced in software (Methods); dendritic bridges were manually counted.
**P<0.05; error bars denote s.e.m. n=6 neurons for both superficial and deep layers of
autism case and n=4 neurons for both superficial and deep layers of control case. n, Three-
dimensional reconstruction of a neuron in layer 2 (superficial) of the autism case. Typical
avoidance of iso-dendritic contact was observed.
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